Short description:

The purpose of this fifth volume in the Global Virology series is to describe and propose vaccines, focusing primarily on viral vaccines. In addition to human vaccines, animal viral vaccines are  included since animals are used in vaccine research, and the spread of diseases to, from, and among animals, birds, and humans permeates the ecosystem. 

Due to climatic, geographical, and social factors, there is increased global spread of viruses and other infectious agents. Contributory factors include global warming, spread of vectors, increased human travel, encroachment into animal and avian environments, war, pestilence, malnutrition, and environmental, economic, and social collapse.  

GVV will address vaccines for many of the viruses addressed in previous series volumes, as well as for viruses not previously covered, and novel and future vaccine technologies.  Advances in vaccine effectiveness and molecular engineering approaches are included, such as gene therapy, and CRISPR technologies.

Long description:

The purpose of this fifth volume in the Global Virology series is to describe and propose vaccines, focusing primarily on viral vaccines. In addition to human vaccines, animal viral vaccines are  included since animals are used in vaccine research, and the spread of diseases to, from, and among animals, birds, and humans permeates the ecosystem. 

Due to climatic, geographical, and social factors, there is increased global spread of viruses and other infectious agents. Contributory factors include global warming, spread of vectors, increased human travel, encroachment into animal and avian environments, war, pestilence, malnutrition, and environmental, economic, and social collapse.  

GVV will address vaccines for many of the viruses addressed in previous series volumes, as well as for viruses not previously covered, and novel and future vaccine technologies.  Advances in vaccine effectiveness and molecular engineering approaches are included, such as gene therapy, and CRISPR technologies.

Table of Contents:

1-15. Individual virus vaccines  (Nipah, Hendra/Nipah/Henipaviridae peptides, Circovirus, Hantavirus, Prion, Influenza, Zika, Venezuelan EEV, HIV, etc.).- 16. Cut-across vaccines.- 17. Strategies in vaccine development and testing.- 18. Prior and anticipated barriers to vaccines.- 19. Sociological and psychiatric barriers to vaccines.- 20. International issues and barriers in vaccine development and promulgation.- 21. Clinical applications of vaccine development, promulgation, and testing.- 22. Applications of CRISPR.- 23. Applications of siRNA.- 24. Nano-molecular vaccine adjuvant technology.-  25. Vaccine development in education.- 26. The intersection of animal, avian, and insect worlds.- 27. Honeybee discrimination.- 28. Jumping genes in maize.- 29. Exclusion of gene expression.